Trials / Completed
CompletedNCT03173586
Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women
Association Between Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 33,000 (actual)
- Sponsor
- Harvard School of Public Health (HSPH) · Academic / Other
- Sex
- Female
- Age
- 30 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is a secondary analysis of data collected in the Nurses' Health Study (NHS) that will evaluat the association between intake of sugar sweetened beverages (SSB), juice and artificially sweetened beverages in relation to biomarkers of hepatic function, lipid metabolism, inflammation and glycemic control.
Detailed description
The investigators will analyze cross-sectional data from 8,492 participants in the Nurses' Health Study who were free of diabetes and cardiovascular disease to evaluate the association between intake of sugar sweetened beverages (SSB), juice and artificially sweetened beverages (ASB) and biomarkers of hepatic function, lipid metabolism, inflammation and glycemic control. Biomarkers were measured from blood samples that were collected in 2 cycles, approximately 10 years apart. Specifically, multivariate linear regression will be used to assess the associations of SSB, ASB, and fruit juice intake with concentrations of fetuin-A, alanine transaminase, gamma-glutamyl transferase, triglycerides, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol, C-reactive protein (CRP), intracellular adhesion molecule 1 (ICAM-1), vascular cell adhesion protein 1 (VCAM-1), adiponectin, insulin, and hemoglobin A1c as well as total cholesterol/HDL-C ratio.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sugar sweetened beverage (SSB) | This is an observational study examining sugar sweetened beverage intake in relation to biomarkers in the NHS. |
Timeline
- Start date
- 1999-09-16
- Primary completion
- 2009-03-31
- Completion
- 2009-03-31
- First posted
- 2017-06-02
- Last updated
- 2017-06-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03173586. Inclusion in this directory is not an endorsement.